Filgrastim biosimilar - Virchow GroupAlternative Names: Neutrogen
Latest Information Update: 30 Aug 2016
At a glance
- Originator Virchow Group
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
- Mechanism of Action Granulocyte colony stimulating factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Neutropenia
Most Recent Events
- 15 Mar 2016 Biomarkers information updated